END STAGE LIVER DISEASE
Clinical trials for END STAGE LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE LIVER DISEASE trials appear
Sign up with your email to follow new studies for END STAGE LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin e derivative tested to stall liver failure in cirrhosis patients
Disease control OngoingThis study tests whether a natural compound called tocotrienol (a form of vitamin E) can slow the worsening of end-stage liver disease in 70 adults with cirrhosis. Participants take either tocotrienol capsules or a placebo twice daily for 3 years. The goal is to see if the treatm…
Matched conditions: END STAGE LIVER DISEASE
Phase: PHASE2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Liver transplant drug may shield kidneys from failure
Prevention ENROLLING_BY_INVITATIONThis study tests whether giving a drug called angiotensin 2 during liver transplant surgery can prevent acute kidney injury, a common and serious complication. About 30 adults with end-stage liver disease will be randomly assigned to receive either the drug plus standard care, or…
Matched conditions: END STAGE LIVER DISEASE
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated May 08, 2026 12:02 UTC
-
Scientists track rare liver diseases in kids to unlock clues
Knowledge-focused TerminatedThis study follows children and young adults with rare mitochondrial liver diseases to learn how these conditions progress over time. Researchers collect medical data and samples like blood and tissue to build a biobank for future studies. The goal is to better understand the dis…
Matched conditions: END STAGE LIVER DISEASE
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC